News
New App Calculates Women’s Risk for Advanced Breast Cancer
Globally, breast cancer is the leading cancer among women. Yet, determining who will develop breast cancer is still a major challenge for the medical community. A new tool, developed by UC San Francisco’s Karla Kerlikowske, MD, and colleagues at other institutions, now helps to calculate risk for
Paid Sick Leave Means More People Get Screened for Cancer
An estimated 300,000 additional employees received colorectal cancer screening in a two-year period, following mandated paid sick leave in 57 metropolitan areas across the U.S. And about 250,000 additional workers underwent breast cancer screenings in a two-year period after the mandate, according
HDFCCC Funds Broad Portfolio of Research Grants Totaling $1 Million
In 2022, the Helen Diller Family Comprehensive Cancer Center funded 25 promising pilot projects totaling $1 million to support cancer research in strategic and developing areas. The projects span basic, translational, and population science from early career and established investigators. The pilot
UCSF is No. 1 Public Recipient of National Institutes of Health Funding in 2022
UC San Francisco received the most funding of any public institution from the National Institutes of Health (NIH) in 2022 for the 16th year running. UCSF was second highest among all the public and private institutions in the country. The University’s total funding came to $823 million, setting a
Science World Honors Kevan Shokat for High-Impact Cancer Research
The UC San Francisco scientist who developed a successful approach to drugging a protein produced by the mutated KRAS gene has won two prestigious awards in the opening weeks of 2023. The discovery, made by Kevan Shokat, PhD, in 2013 opened up new avenues for cancer treatment and research. Mutations
“Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
A novel UC San Francisco study that aims to transform breast cancer screening is expanding to reach women as young as 30, with the intention of including thousands of women who could be at higher risk of developing aggressive cancer. The expanded study, known as WISDOM 2.0, is testing a personalized
If Immunity Is Innate, What Impacts Our Ability to Fight Infections?
As an assistant professor of pharmaceutical chemistry at UC San Francisco, Balyn Zaro, PhD, is drawn to genetic differences in the innate immune system. After all, those differences can impact the effectiveness of the medications we take. Her lab investigates the cause and consequence of genetic